• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在嗜铬细胞瘤切除术中麻醉期间使用拉贝洛尔。

Use of labetalol during anesthesia for pheochromocytoma removal.

作者信息

Van Stratum M, Levarlet M, Lambilliotte J P, Lignian H, de Rood M

出版信息

Acta Anaesthesiol Belg. 1983 Dec;34(4):233-40.

PMID:6673473
Abstract

Labetalol, an alpha and beta adrenergic blocking drug, was used during anesthesia for removal of a very large pheochromocytoma which was predominantly epinephrine secreting. The 70-year-old female patient suffered from angina pectoris and chronic bronchitis. A preoperative treatment including an alpha-adrenolytic drug was administered but beta-adrenergic blockers were avoided because of the risk of cardiac decompensation and bronchoconstriction. During the operation, hypertensive peaks were easily controlled by bolus injections of labetalol 20 mg. The removal of the tumor was followed by a transient moderate hypotension. Heart rate remained stable throughout the operation. No hemodynamic problems occurred during the postoperative period. With regard to this case, a summary of the literature concerning the properties of labetalol is presented.

摘要

拉贝洛尔是一种α和β肾上腺素能阻断药物,在麻醉期间用于切除一个非常大的、主要分泌肾上腺素的嗜铬细胞瘤。这位70岁的女性患者患有心绞痛和慢性支气管炎。术前给予了包括α-肾上腺素能阻断药物在内的治疗,但由于存在心脏代偿失调和支气管收缩的风险,未使用β-肾上腺素能阻滞剂。手术期间,通过静脉推注20毫克拉贝洛尔可轻松控制高血压峰值。肿瘤切除后出现了短暂的中度低血压。整个手术过程中心率保持稳定。术后期间未出现血流动力学问题。关于该病例,本文对有关拉贝洛尔特性的文献进行了总结。

相似文献

1
Use of labetalol during anesthesia for pheochromocytoma removal.在嗜铬细胞瘤切除术中麻醉期间使用拉贝洛尔。
Acta Anaesthesiol Belg. 1983 Dec;34(4):233-40.
2
[Labetalol in the intraoperative control of pheochromocytoma].
Lijec Vjesn. 1983 Jul-Aug;105(7-8):304-6.
3
Labetalol in the treatment of a patient with phaechromocytoma: a case report.拉贝洛尔治疗嗜铬细胞瘤患者:一例报告
Br J Clin Pharmacol. 1979;8(Suppl 2):141S-142S.
4
Current status of labetalol, the first alpha- and beta-blocking agent.拉贝洛尔(第一种α和β受体阻滞剂)的现状
Int J Clin Pharmacol Ther Toxicol. 1985 Nov;23(11):617-28.
5
[Malignant pheochromocytoma: blood pressure controlled by labetalol].[恶性嗜铬细胞瘤:拉贝洛尔控制血压]
Nihon Hinyokika Gakkai Zasshi. 1984 Mar;75(3):523-7.
6
[Use of labetalol in the treatment of hypertensive crises].拉贝洛尔在高血压急症治疗中的应用
G Ital Cardiol. 1982;12(5):355-8.
7
Use of labetalol during hypotensive anaesthesia and in the management of phaeochromocytoma.拉贝洛尔在低血压麻醉及嗜铬细胞瘤治疗中的应用。
Br J Clin Pharmacol. 1979;8(Suppl 2):229S-232S.
8
[Anesthetic management for a child with bilateral pheochromocytoma].[双侧嗜铬细胞瘤患儿的麻醉管理]
Masui. 2010 Mar;59(3):397-400.
9
Labetalol in the preoperative management of phaeochromocytoma.拉贝洛尔在嗜铬细胞瘤术前管理中的应用
Anaesth Intensive Care. 1982 May;10(2):160-3. doi: 10.1177/0310057X8201000216.
10
[Anesthetic management for off-pump coronary artery bypass grafting in a patient with a pheochromocytoma and followed by the resection of the pheochromocytoma].[嗜铬细胞瘤患者非体外循环冠状动脉旁路移植术的麻醉管理及随后的嗜铬细胞瘤切除术]
Masui. 2007 Feb;56(2):190-2.

引用本文的文献

1
Pheochromocytoma - update on disease management.嗜铬细胞瘤 - 疾病管理更新。
Ther Adv Endocrinol Metab. 2012 Feb;3(1):11-26. doi: 10.1177/2042018812437356.
2
Pheochromocytoma: implications in tumorigenesis and the actual management.嗜铬细胞瘤:在肿瘤发生中的意义及实际管理
Minerva Endocrinol. 2012 Jun;37(2):141-56.
3
Pheochromocytoma and paraganglioma.嗜铬细胞瘤和副神经节瘤。
Prog Brain Res. 2010;182:343-73. doi: 10.1016/S0079-6123(10)82015-1.
4
Perioperative management for resection of a malignant non-chromaffin paraganglioma of the bladder.
Can J Anaesth. 1989 Mar;36(2):215-8. doi: 10.1007/BF03011448.